LAB
Standard BioTools Inc. · Healthcare
Caligan Partners LP bought $1.9M of Standard BioTools Inc.
10% owner
Bought$1,922,463
$3.77Price
509,573Shares
+3%Stake
What LAB did for a copier
Prices for LAB after this filing aren't in yet.
Caligan Partners LP's record
6 other buys with 3 months of prices since 2022: on average +23.2% against the S&P 500, and 5 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Apr 6. Filed Fri, Apr 8, 1:19 PM ET, during the session. Not investment advice.